Winton Capital »

Soleno Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0M 44k 46.30

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Intel Corporation (INTC)
Devon Energy Corporation (DVN)
Solstice Advanced Matls Com Shs (SOLS)
Epam Systems (EPAM)
Chart Industries (GTLS)
Hologic (HOLX)
Electronic Arts (EA)
Ceridian Hcm Hldg
Masco Corporation (MAS)
Boeing Company (BA)
Five Below (FIVE)

View all positions for Winton Capital

Top funds holding Soleno Therapeutics

FMR
Henderson Group
BlackRock
Vanguard Group
venBio Select Advisor
State Street Corporation
Wellington Management Company
Nantahala Capital Management
Adage Capital Partners GP
Millennium Management
Commodore Capital
Braidwell
Geode Capital Management
Polar Capital Holdings
Woodline Partners

View all funds holding Soleno Therapeutics